Scaling-up a new socio-mental health service model in Iran to reduce burden of neuropsychiatric disorders: an economic evaluation study by Hosseini Jebeli, S.S. et al.
Hosseini Jebeli et al. Int J Ment Health Syst           (2021) 15:47  
https://doi.org/10.1186/s13033-021-00468-w
RESEARCH
Scaling-up a new socio-mental health 
service model in Iran to reduce burden 
of neuropsychiatric disorders: an economic 
evaluation study
Seyede Sedighe Hosseini Jebeli1, Aziz Rezapour2* , Ahmad Hajebi3, Maziar Moradi‑Lakeh4 and 
Behzad Damari5^ 
Abstract 
Background: The integration of core packages of mental health care into routine primary health care has been 
introduced as an effective way to achieve universal health coverage in mental health care. Based on the transition of 
mental health care in Iran, from introducing basic mental health care in PHC to the experience of community‑based 
mental health centers for urban areas, a new socio‑mental health service model has been so far proposed. This study 
aimed to estimate the impact of scaling‑up the new socio‑mental health model at the national level as well as its 
associated costs.
Methods: This study was a cost‑consequence analysis following One Health Tool methodology. The data required for 
the study were collected in the first quarter of the year 2020 with a time horizon from 2020 to 2030. The selected met‑
ric for summarizing health effects is healthy life years gained. Resources used in terms of drug and supply, staff salaries 
and outpatient visits were documented and associated costs were subsequently estimated in order to estimate the 
average cost of each intervention per case.
Results: The health impacts are calculated in terms of healthy life years gained for 2020–2030, after adjusting the 
prevalence and incidence rates for each disorder. In total, 1,702,755 healthy life years were expected to be gained. 
Considering total 1,363,581,654 US dollars cost in base case scenario, each healthy life years gained will cost around 
801 US dollars. Based on the WHO criteria for cost‑effectiveness threshold, all of the values ranged from 724 to 1119 
US dollars obtained through eight different scenarios were considered as cost‑effective given the GDP per capita of 
5550 US dollars for Iran in 2018.
Conclusions: Mental health budget in Iran equals to about three percent of total health expenditure while the men‑
tal health cost per capita is estimated to be 1.73 US dollar which are relatively low considering the share of the MNS 
disorders in the national burden of diseases. The results of current study showing the cost of 16.4 US dollar per capita 
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Deceased—Behzad Damari. His great contributions in improving the 
mental health system in Iran and introducing the new socio‑mental 
health model is highly appreciated
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Introduction
Mental health is regarded as an integral part of an indi-
vidual’s capacity to lead a fulfilling life. Disturbances of a 
person’s mental well-being can thus adversely compro-
mise this capacity as well as choices made in this respect, 
resulting not only in diminished functioning at individual 
level but also broader welfare losses for households and 
society [1].
Although effective interventions have been thus far 
introduced and affordable methods for their delivery 
have been shown to work, scaling-up the quality of men-
tal health services has not occurred in most countries. 
Accordingly, mental health care should be included as an 
essential component of universal health coverage (UHC) 
and even fully integrated into global response to other 
health priorities whereas access to quality of care and 
financial risk protection is ensured [2].
To note, depression and anxiety are also responsible for 
more than 10% of the global burden of disease (GBD) and 
cost $1 trillion every year in terms of lost productivity. 
This is accordingly a significant cost with regard to the 
years of (healthy) life lost (YLL) and the existing situation 
makes life much harder for the most vulnerable people 
in the world. Three quarters of the mental health disease 
burden is observed in low-to-middle-income countries 
(LMICs), and governments and households—those least 
able to afford it—bear the burden of mental health care 
costs [3].
Current coverage of essential mental health care ser-
vices in LMICs is very limited. Resources made avail-
able by governments for provision of community-based 
and person-centered mental health care services are 
often very modest. The resources that are made avail-
able are also typically directed towards more specialized 
and institutional services, which are not easily accessi-
ble. Without appropriate access to decent services and 
adequate protection, individuals with mental disorders 
and their families are correspondingly facing a difficult 
choice, namely, paying out of pocket for treatments of 
variable and sometimes poor quality or going without 
treatments altogether [4].
The economic consequences of low investments in 
mental health are staggering, with an estimated loss of 
US $16 trillion to the global economy due to mental dis-
orders (for the period: 2010–2030), driven in part by the 
early age of onset and loss of productivity across the life 
course. In 2011, the Grand Challenges in Global Mental 
Health initiative led by the United States (US) National 
Institute of Mental Health (NIMH) prioritized imple-
mentation research questions to reduce treatment gaps 
for mental disorders. The first priority identified was the 
integration of core packages of mental health care ser-
vices into routine primary health care (PHC) ones [2].
Addressing the large and growing burden of men-
tal, neurological, and substance use (MNS) disorders 
at the population level via scaled-up implementation 
of evidence-based treatment and prevention has been 
repeatedly essential over the past decade, and it can be 
expected to place new resource demands on the health 
systems of LMICs [4].
In Iran, about three percent of health care expenditure 
is allocated to mental health [5]. There are 20 mental 
health workers per 100,000 Iranians as for 2017 which has 
a significant increase compared to 11 per 100,000 popu-
lation in 2011. The breakdown according to profession is 
as follows: psychiatrists (2.2 per 100,000), child psychia-
trists (0.15 per 100,000), other medical doctors, not spe-
cialized in psychiatry (0.63 per 100,000), nurses (9.45 per 
100,000), psychologists (5.17 per 100,000), social work-
ers (1.51 per 100,000), occupational therapists (1.01 per 
100,000) and speech therapist (0.63 per 100,000). Nearly 
5192 in 100,000 of the general population visit outpatient 
facilities, mostly community-based facilities, while there 
are about 28.5 beds per 100,000 populations, in various 
settings including community-based facilities and hospi-
tals [6].
Based on the transition of mental health care in Iran 
within about 2 decades, from introducing basic men-
tal health care in PHC to the experience of community-
based mental health centers (CMHC) for urban areas [7], 
a new socio-mental health service model, with two basic 
and advanced service strata, has been so far proposed. 
The given model has been piloted in eight cities in this 
country over the last 5 years.
The first mental health program was piloted from 1992 
to 1994 and after more than two decades, it now covers 
18 million (82.8%) rural residents and 10 million (21.7%) 
citizens in urban areas. The program mainly addressed 
severe mental health disorders, epilepsy, and mental 
retardation. While it has been proven successful for 
for scaling up this comprehensive mental health service model can convince high‑level policy‑makers to increase the 
share of mental health budget accordingly. The present study demonstrated that the cost in this new socio‑mental 
services model is not substantial compared with GDP per capita of Iran.
Keywords: Mental health, Economic evaluation, Universal health coverage
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villages, this program is not sufficient for those residing 
in urban areas. In response to the need of urban dwellers, 
the structure of CMHC for urban areas was designed to 
target those with neurotic disorders including depression 
and anxiety as well as severe mental disorders such as 
schizophrenia, bipolar disorder, and suicide attempts [8].
The new socio-mental health service model is thus 
comprised of two levels of health services, i.e., basic and 
advanced mental health services. The basic level services 
include public education on the basics of socio-mental 
health skills and screening. At this level, cases with target 
mental conditions are recognized by community health 
workers and then referred to mental health specialists for 
further evaluations and interventions. Using an inter-sec-
torial approach, patients in need of social services should 
be referred to a relevant service provided by other organ-
izations in order to strengthen their social support [8].
The advanced socio-mental health services take 
account of facilities for mental and social emergencies 
and provide treatments for referrals from level one. Such 
services should be delivered by a collaborative care team 
comprised of psychologists, clinical psychiatrists, etc. at 
the integrated mental health settings such as PHC health 
centers, CMHCs, and hospitals [8].
Accordingly, scaling-up mental health services in a suc-
cessful manner involves putting a range of human, physi-
cal, and other resource inputs together in order to deliver 
interventions and services capable of improving mental 
health status and related outcomes. In view of that, an 
essential element of evidence-based mental health ser-
vice planning and scaling-up is related to an assessment 
of what resources are required for delivering of services 
to populations in need and meeting program goals [9].
Therefore, this study aimed to estimate the impact of 
scaling-up the new socio-mental health model at the 
national level as well as its associated costs to make an 
investment case to be considered by policy-makers for 
further evidence-based policy-making. The perspective 
chosen for this study is healthcare system, specifically 
ministry of health which responsible for providing men-
tal health services through primary healthcare settings 
and hospitals. While healthcare perspective provides 
a straightforward analysis of costs and health gains for 
policy makers, the societal view can capture both costs 
and impacts in a comprehensive scale which will be more 
convincing once the evidence is use for budget negotia-
tion at national level. Although, considering social costs 
is often in favor of cost-effectiveness of mental health 
interventions [10], the societal perspective has not been 
taken into account as the OHT methodology does not 
provide technical capacity for such estimation.
Methodology
Study design and tools
This study was a cost-effectiveness analysis to examine 
the expected health gains of scaling-up certain inter-
ventions as well as their costs to reduce the burden of 
mental disorders in different groups of patients suffer-
ing from anxiety, depression, bipolar disorder, and epi-
lepsy in Iran. The scaling-up scenario was thus tested 
against the no scaling-up scenario with the existing level 
of care offered in the system. The data required for the 
study were collected in the first quarter of the year 2020 
and the time horizon was a 10-year period from 2020 to 
2030. Although the amount of services provided in the 
private sector is considerable and provides 75% of out-
patient services [11], in this study we assumed ministry 
of health as the single provider in order to restrict the 
scope of research and gather high quality data to make 
precise estimations. It was therefore assumed that all the 
services were being provided by the government within 
the facilities of the Ministry of Health and Medical Edu-
cation (MOHME) and the analysis was fulfilled based on 
its perspective.
One health tool module on MNS disorders
The OneHealth Tool (OHT), a software tool developed 
by the international costing experts from the World 
Health Organization (WHO) and other United Nations 
(UN) agencies, was employed to start this study. The 
mental health module of the OHT was accordingly devel-
oped in order to ensure that the national mental health 
development plans have been carried out within a frame-
work of assessment of overall health system capacity and 
to take financial sustainability and outcomes-based plan-
ning into account [12].
Research planning
Consulting with three main national planners at the 
Department of Mental Health in the MOHME who are in 
charge of this program, priority MNS disorders including 
major depression, anxiety, bipolar disorder, and epilepsy 
were selected.
The main criteria to select these interventions include: 
(1) Provision of care within the centers affiliated by min-
istry of health: for instance, the drug abuse treatment 
was excluded as the services are mainly provided in other 
sectors; (2) Burden of diseases: as reflected in the intro-
duction, these disorders are among most prevalent ones 
in national and global level; and (3) The inclusion of the 
interventions in OHT impact module: Since not all of 
the interventions are included in this module to estimate 
health impacts, we checked the available interventions 
and excluded ones which are not provided in impact 
modules and finalized eight interventions.
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It is noteworthy that these interventions are recom-
mended in WHO Mental Health Gap Action Program 
(mhGAP) guideline [13] as standard and effective inter-
ventions. So, their effectiveness is proved through RCTs 
and Systematic reviews which are formulated in the OHT 
to estimate the health impacts. Although national estima-
tion of effectiveness would better describe the situation 
but it hasn’t been in the scope of this study to estimate 
these measures and no national studies were available. 
Therefore, we relied on the global and regional evidence 
of effectiveness in the OHT.
Moreover, appropriate mental health care packages 
and scenarios, current and target coverage levels for spe-
cific intervention strategies, and scaling-up period were 
identified through consultations with the expert group of 
national planners and program managers.
For clinical-level consideration of resource use profiles 
for different disorders and interventions, unit costs and 
prices for health care services and commodities (such as 
those for staff salaries, outpatient visits, and psychotropic 
medications), one of the pilot sites (namely, the city of 
Oskoo in East Azerbaijan Province) was selected. This 
new service model was initially implemented in three cit-
ies [14]. Although a formal evaluation was not performed 
to compare the process in these three pilot sites, based 
on the regular observations, national managers of the 
program believe that Oskoo is the best practice to the 
program, benefiting from excellent documentation and 
assessments. To collect these data inputs, the research 
team, working with local team members and other 
national staff, identified and utilized local data sources 
and visited the site in a 3-day tour. The data checklist 
adapted from the study by Chisholm [12] was also modi-
fied and used in order to facilitate and document the pro-
cess of data contextualization.
Data contextualization
Health impacts
The selected metric for summarizing health effects at 
the population level is (healthy) life years (LYs) gained 
[equivalent to disability-adjusted life years (DALYs) 
averted], where one DALY could be thought of as one 
YLL. (Healthy) LYs is also computed with reference to 
country-specific life tables that have been already built 
into the model, and reflect the combined time spent 
by the population in a particular state of health with a 
known degree (or free) of disability. Disability levels were 
drawn from the GBD 2010 study [15]. Implementing or 
scaling-up an effective intervention in the population 
was thus modeled to reduce the time spent in a disabling 
state, either by reducing prevalence (e.g., by decreas-
ing the number of new cases or increasing the remission 
rate), or by improving the level of functioning in people 
with the condition in question [12].
Epidemiology
Iran has a history in mental health surveys and it is 
therefore possible to make use of high-quality epidemi-
ological data from the national surveys [16–18]. How-
ever, to meet age-stratified data sheets of the OHT on 
the prevalence and incidence rates for all disorders, the 
2017 GBD estimates available in GBD result tool (http:// 
ghdx. healt hdata. org/ gbd- resul ts- tool) were used. The 
prevalence and incidence rates were extracted for the 
four disorders including depression, anxiety, bipolar and 
epilepsy and the data were sorted for male and female in 
17 age groups. Then, to meet the OHT requirements for 
data entry, these rates were modified to cases per 1,000 
population.
Estimating resources, costs, and coverage levels
The key categories of health service costs in the OHT 
included drug and supply costs (e.g., daily dose of a 
generically produced first-line anti-psychotic or anti-epi-
leptic medication), costs of response to ambulatory con-
tacts by mental health or general health workers (such as 
psychologists, counselors, and community health work-
ers), and costs of hospital-based outpatient/inpatient care 
services. In addition, program-level resource needs were 
identified, including overall program management and 
administration as well as training [12].
Intervention costing
Resources used in terms of drug and supply, staff sala-
ries, and outpatient visits were documented through 
field visits to the pilot site and the associated costs were 
subsequently estimated based on accounting documents 
available in the program management office in order to 
estimate the average cost of each intervention per case.
As described in the introduction of the new care 
model, basic package of care (e.g., basic psychosocial 
treatment plus medication therapy of moderate cases of 
anxiety/depression) were being provided in health care 
facilities and severe cases of those disorders in addition 
to all bipolar cases could be referred to the CMHCs for 
intensive care and social support. It is noteworthy that 
the WHO mhGAP guideline was practiced with slight 
changes in real time spent and availability of recom-
mended drugs in the whole system of integrated mental 
health care in PHC.
All three levels of care [health care facility, CMHC, 
and general hospital (psychiatric ward)] were accord-
ingly visited and all staff including community health 
workers, socio-mental health experts, general practition-
ers, psychologists, psychiatrists, and social workers were 
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interviewed in order to identify activities and estimate 
time spent for each patient and intervention. The drug 
and supply list used for each intervention was also docu-
mented and the price list was acquired from the health 
information system (HIS) of the hospital with a particu-
lar focus on most-prescribed medications available in the 
primary care setting. It should be noted that drug and 
supply prices have the same tariffs across the country in 
public hospitals and the PHC network.
Program costing
Program specific costs concern the cost incurred at the 
national and provincial level to manage and supervise 
the program. Information on the program-specific staff 
required for scaling-up were obtained from background 
strategic documents of the program available at the 
Department of Mental Health including a unit cost study 
of new socio-mental program, so-called SERAJ, in the 
year 2018 [19]. In order to estimate the cost of supervi-
sion and auditory visits as well as necessary trainings, the 
district managers were interviewed in the field visit and 
costing parameters including transportation, trainings 
and allowances to take part in missions were identified.
Total cost
The total costs of scaling-up an intervention in a given 
year for a country was thus derived by multiplying 
resource use needs by their respective unit costs to give 
an average cost per case. It was then multiplied by the 
total number of cases, expected to receive a particular 
intervention (given by the prevalence of the disorder 
multiplied by the rate of treatment coverage of specific 
intervention strategies in the population), that is, total 
cost = population × prevalence rate × coverage × treat-
ment cost per case [12]. To estimate the costs, the 
expected inflation rate for the period: 2020–2030 was 
applied using extrapolation based on the actual inflation 
rates for 2010–2019. Since all the costs were calculated 
in Iranian Rial (IRR), to convert the costs in US $, the 
exchange rate for the study period was estimated through 
extrapolation based on the UN exchange rates for the 
past 10 years.
Coverage
In order to estimate present and future coverage levels, 
we have conducted three rounds of panel discussions 
with three national policy makers and three provincial 
managers who have been in charge of this program at 
national and district levels. The first panel was conducted 
at the beginning of the research, the second one was just 
at the early beginning of data collection and the last one 
during the filed visit in the pilot site. All the estimations 
of coverage were made based on the population covered 
in each area and expected coverage in the future based 
on the available budget. In order to make sure about cov-
erage levels, we re-checked measures before and after 
field visits and examined different scenarios.
The estimates of the baseline coverage were based 
on the coverage of health care facilities per population. 
Given the expected challenges of scaling-up the new 
model at the national level, a modest coverage target of 
30–40% by 2030 was set for the intensive packages of care 
and 60–70% target coverage was considered for the basic 
package, which have already had 40% baseline coverage.
Assumptions
In this study, the volume of services provided in the pri-
vate sector was not estimated. It was assumed that all the 
services had been provided by the government within 
the facilities of MOHME. Besides the base case scenario 
which is provided below, we examined seven others sce-
narios in order to provide a sensivity analysis.
Currencies reported
At first, all the costing parameters were estimated in 
IRR (Iranian Rial) as local currency values were used in 
the context of ongoing policy dialogue, then all the cost 
values were converted into the US dollars for ease of 
interpretation and comparison. The exchange rate was 
captured from the UN exchange rates in June 2020 which 
equals to 194,881 IRR.
In addition, the final result of cost per each health life 
years were also reported in Intl dollars (PPP adjusted) to 
provide a more realistic view while the results are com-
pared to that of different countries. In order to convert 
values to Intl dollars we used the cost conversion tool 
developed by Campbell Collaboration (https:// eppi. ioe. 
ac. uk/ costc onver sion/). The underlying methods of this 
tool is provided in the paper published in the journal Evi-
dence and Policy [20].
Results
After consulting the national managers of the program, 
the baseline coverage levels (2020) as well as the target 
ones (2030), were defined for each of the interventions. 
Among different scaling-up patterns available in the tool 
including linear, S-shaped, front-loaded, and exponential, 
the front-loaded interpolation pattern, recommended 
for middle-income countries was chosen. Front loaded 
interpolation is basically applying a calculation pattern 
to reflect an assumption that scaleup happens relatively 
quickly (in the first years of the projection) and then cov-
erage increases slow down. We tend to see this kind of 
pattern when the building blocks are in place to roll out a 
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new service or expand an existing one. The coverage lev-
els for all the interventions in each year are presented in 
Table 1.
The total cost including both intervention and pro-
gram costs for all interventions selected from the mod-
ule of mental and neurological disorders are illustrated in 
Table 2. To note, all the cost values were converted into 
the US dollars for ease of interpretation and compari-
son, but local currency values were used in the context of 
ongoing policy dialogue. The exchange rate was captured 
from the UN exchange rates in June 2020 which equals to 
194,881 IRR.
As shown in Table 3, the health impacts are calculated 
in terms of (healthy) LYs gained for 2020–2030, after 
adjusting the prevalence and incidence rates for each 
disorder in the NCD impact module. Depression has 
the biggest share in the health impact, as it is the most 
prevalent mental disorder in Iran. In total, 1,702,755 
(healthy) LYs were expected to be gained via scaling-
up the program at national levels. Considering the total 
1,363,581,654 US dollars cost, each (healthy) LY gained 
will cost around 801 US dollars.
In order to provide a sensivity analysis, we have exam-
ined three sets of scenarios changing the scale up pat-
terns, investigating the lower and upper bound of 
Confidence Intervals (CIs) for prevalence and incidence 
rates and finally changing the coverage levels.
As shown in the Table  4, the cost per a healthy LY 
changes from 1199 US $ in exponential pattern to 959 in 
linear one. Based on the health system development level 
in Iran, the front-loaded pattern, recommended for mid-
dle income countries, is selected and other scenarios are 
tested against it.
Then, in the next set of scenarios, the epidemiological 
data, obtained from GBD estimates, were changed using 
the CIs of reported prevalence and incidence rates result-
ing in a range of 794 to 807 US dollars per each healthy 
LY gained.
Finally, we have examined different coverage levels as 
the main driver for costs and impacts. In the scenario 
“Coverage 1”, we have changed the existing coverage of 
basic interventions from 40 to 50% while in the “Coverage 
2” scenario the target level for intensive care was adjusted 
for 40% instead of 30% in base case scenario. Moreover, 
in the scenario “Coverage 3” the target level for the basic 
package were reduced considering 60% level of coverage.
Based on the WHO criteria [21], all of these values 
ranged from 724 to 1199 US $ obtained through eight dif-
ferent scenarios were considered as cost-effective.
Discussion
In the face of large and increasing burden of mental dis-
eases and treatment gaps existing in Iran, a new socio-
mental health service model was introduced to the 
mental health system of this country. This program, avail-
able in PHC settings, could significantly contribute to 
achieving the goals of the UHC for the MNS disorders in 
terms of financial protection and service provision. This 
study was further concerned with informing national 
policy-makers about resource needs and costs of scaling-
up such mental health services in national level.
The OHT methodology used by Chisholm [12] was fol-
lowed in this study. In comparison with their estimation 
for five LMICs, the results of this study indicated that the 
resource needs for scaling-up mental health services did 
not need to be substantial. Although differences in health 
system development, service packages, and costing 
requirements make it much difficult to compare results 
between various countries in such studies, the cost esti-
mated here for Iran in the base case scenario was 801 US 
dollars in terms of cost per (healthy) LY gained. This value 
was far less than what was estimated for South Africa, 
around 18,000 US dollars, whose per capita income was 
comparable to that of Iran as a middle-income country. 
This estimation was somehow analogous to that of India 
with 761 US dollars per (healthy) LY gained from scaling-
up their mental health program [12].
In another cost-effectiveness analysis of an essential 
mental health intervention package in Nigeria [22], the 
cost per each DALY averted for a package of care includ-
ing depression, schizophrenia, epilepsy, and hazardous 
alcohol use was estimated 320 US dollars. In addition, 
the study of cost-effectiveness of the Mental Health and 
Development model for schizophrenia-spectrum and 
bipolar disorders in rural Kenya [23] estimated the cost 
Table 3 Healthy years gained
Impact scale up 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 Total
Depression 0 35,873 59,717 78,750 95,490 110,979 125,688 139,854 153,611 167,043 180,231 1,147,236
Anxiety 0 8235 13,966 19,595 25,477 31,699 38,272 45,177 52,380 59,847 67,544 362,192
Bipolar 0 4461 6371 7658 8660 9498 10,229 10,884 11,480 12,027 12,534 93,802
Epilepsy 0 1691 3423 5199 7018 8879 10,774 12,698 14,645 16,610 18,588 99,525
Total 0 50,260 83,477 111,202 136,645 161,055 184,963 208,613 232,116 255,527 278,897 1,702,755
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of a DALY averted around Int $727 from the health sys-
tem perspectives.
In a more recent study in Ethiopia, a cost-effectiveness 
analysis about scaling-up essential neuropsychiatric ser-
vices for treatments of depression, schizophrenia, bipolar 
disorder and epilepsy were performed [24]. Based on the 
results of this study, treatment of epilepsy with a first-
generation antiepileptic drug is the most cost-effective 
treatment (US $321 per DALY adverted). Treatments for 
depression have mid-range values compared with other 
interventions (US $457–1026 per DALY adverted). Treat-
ments for schizophrenia and bipolar disorders are least 
cost-effective (US $1168–3739 per DALY adverted). Gen-
erally, the cost of bipolar and schizophrenia treatments 
are two or three times higher than that of depression and 
epilepsy which often don’t need hospitalization and spe-
cialist services.
In the present study, through examining different sce-
narios, it was shown that achieving more coverage level 
in new socio-mental health in terms of increased level 
of intensive care package (increasing the expected level 
from 30 to 40%) could significantly reduce the cost per 
each (healthy) LY gained from 801 US $ in base case 
compared to 724 US $ in respective scenario. It means 
that by expanding this new service model aimed at urban 
population, more (healthy) LY will be gained and the cost 
per each (healthy) LY will decrease. Comparisons made 
between different scenarios show that introduction of 
this new service model in urban areas is cost-effective 
while the basic package of care is well-developed in rural 
areas. It is noteworthy that all the health gains based on 
the base case would cost 16.4 US dollar per capita in the 
next 10 years from the health system perspective which is 
not substantial compared to the health expenditure per 
capita equal to 484 US dollars as for 2018 (https:// data. 
world bank. org/ indic ator/ SH. XPD. CHEX. PC. CD? locat 
ions= IR) and can in turn greatly increase the access to 
the mental health care by citizens and is considered an 
important step forward in order to achieve universal 
health coverage in mental health. In addition, as reported 
in an economic analysis study [25] based on the unit costs 
of this program in the pilot level, considering 116,570 
people in order to be screened and treated within this 
model, the per capita cost was estimated 5.56 US dollar 
which seems comparable to our estimation as we did a 
prospective estimation in the national level for the next 
10 years considering inflation rate.
Furthermore, based on 2014 atlas of mental health 
[26], the per capita mental health cost in Iran is 
reported 1.73 US dollars while in the same year the 
health expenditure per capita equals to 432 US dol-
lars. This figure demonstrates how neglected is the 
mental health sector and how this new service model 
could contribute to greater access and improved mental 
health with relatively small amount of funds.
Furthermore, based on the WHO criteria for cost-
effectiveness threshold [21], cost per (healthy) LY 
gained (i.e., DALY averted) was considered very cost-
effective if it was less than a gross domestic product 
(GDP) per capita in a specified country. The estima-
tion of 801 US dollars (7714 Intl dollars) per (healthy) 
LY gained through the scaling-up period of the new 
Table 4 Sensivity analysis
Scenarios Base case (front 
loaded)
Scale up pattern Epidemiologic data CIs Expected coverage levels
Exponential Linear Lower Upper Coverage 1 Coverage 2 Coverage 3
Intervention 
costs
382,120,919 390,611,079 387,772,875 305,783,940 476,662,810 392,627,220 448,247,779 372,911,819
Program costs 8,736,258 8,736,258 8,736,258 8,736,258 8,736,258 8,736,258 8,736,258 8,736,258
Labor costs 972,724,477 994,357,774 987,228,401 778,324,069 1,213,512,516 1,014,058,490 1,065,250,321 934,160,222
Total costs 1,363,581,654 1,393,705,112 1,383,737,535 1,092,844,267 1,698,911,584 1,415,421,968 1,522,234,357 1,315,808,299
Impact scale up
 Depression 1,147,236 753,131 957,688 934,294 1,403,864 1,105,159 1,439,832 1,105,371
 Anxiety 362,192 282,307 324,450 316,006 418,867 310,894 435,672 311,346
 Bipolar 93,802 38,658 67,133 65,494 130,647 93,802 128,165 93,802
 Epilepsy 99,525 88,300 94,216 61,126 150,542 65,234 99,525 65,716
 Total impact 1,702,755 1,162,396 1,443,487 1,376,920 2,103,920 1,575,089 2,103,194 1,576,235
 Cost per a 
healthy LY 
(US $)
801 1199 959 794 807 899 724 835




7714 11,548 9236 7647 7772 8658 6973 8042
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socio mental health care could be regarded cost-effec-
tive as well given the GDP per capita of 5550 US dol-
lars (12,937 Intl dollars) for Iran in 2018 (2019) (https:// 
data. world bank. org/ indic ator/ NY. GDP. PCAP. PP. CD? 
locat ions= IR).
Therefore, the health returns on such an invest-
ment are substantial. Such information on the costs 
and health impacts of scaling-up could further provide 
important evidence that could be used in dialogues 
with health planners and policy-makers at the national 
level, particularly in the context of increased policy 
attention to the rising burden of mental and neurologi-
cal disorders.
The estimates reported herein additionally repre-
sented an initial set of projections, based on national 
available evidence and informed inputs of local experts; 
however, such estimates are subjected to further dis-
cussions, reviews, and revisions as planning cycles and 
political processes are evolving. New projections will 
be accordingly prepared in the light of changes to poli-
cies and plans, such as revised target coverage levels or 
lengthened implementation periods.
Conclusion
Mental health budget in Iran equals to about three per-
cent of total health expenditure while the mental health 
cost per capita is estimated to be 1.73 US dollar [5, 26], 
which are relatively low considering the share of the 
MNS disorders in the national burden of diseases. The 
results of current study showing the cost of 16.4 US dol-
lar for scaling up this comprehensive mental health ser-
vice model besides previous studies (19, 25) reporting 
5.56 US dollar per each person, can convince high-level 
policy-makers to increase the share of mental health 
budget accordingly. Using the OHT strategic planning 
reflecting on the expected health gains and the associ-
ated costs, could help policy-makers with evidence-
informed policy- making to prioritize cost-effective 
interventions and to improve allocative efficiency. The 
present study provided a timely analysis as the Depart-
ment of Mental Health in Iran sought to implement an 
ambitious plan of mental health scaling-up across the 
country, collaborating with the MOHME and the Minis-
try of Interior. Therefore, this work could make a useful 
contribution to state-level deliberations on the imple-
mentation of this plan at national level. Expanding such 
works beyond the mental health to all non-communi-
cable diseases (NCDs) and making comparisons within 
and between specific packages of cares can be thus great 
evidence while the programs are developing at different 
departments aimed to be scaled-up at national and sub-
national levels.
Limitations
Working with the OHT through different modules can 
be a challenging job with hundreds of parameters to be 
revised and updated. A broad concern is also related to 
the available national evidence on a number of domains. 
These include epidemiological data on the burden of 
the MNS disorders, extent of current coverage and 
expenditure, as well as evidence base for locally adapted 
cost-effective interventions. While regional and global 
default estimates are available, the tool developers 
strongly encourage updating parameters with national 
estimates.
To update the prevalence and incidence rates, the 
GBD estimates were accordingly used as the last 
national mental health survey of Iran did not include 
estimates on the incidence rates while the prevalence 
rates had been also limited to major depression and 
anxiety. In case of cost-effectiveness of interventions 
and transition rates (e.g., remission and mortality rates), 
the default OHT rates were employed, since there were 
no national estimates or even studies investigating such 
parameters.
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